CME Group (CME) Aktievy
CME Group Inc. driver tillsammans med sina dotterbolag kontraktsmarknader för handel med terminer och optioner på terminskontrakt över hela världen. Mer information
| Snöflinga Score | |
|---|---|
| Värdering | 2/6 |
| Framtida tillväxt | 0/6 |
| Tidigare resultat | 4/6 |
| Finansiell hälsa | 5/6 |
| Utdelningar | 4/6 |
CME Community Fair Values
Create NarrativeSee what 97 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
CME Group Inc. Konkurrenter
Prishistorik och prestanda
| Historiska aktiekurser | |
|---|---|
| Aktuell aktiekurs | US$262.17 |
| 52 veckors högsta | US$329.16 |
| 52 veckors lägsta | US$218.31 |
| Beta | 0.27 |
| 1 månads förändring | 6.96% |
| 3 månaders förändring | -11.93% |
| 1 års förändring | -4.29% |
| 3 års förändring | 27.27% |
| 5 års förändring | 32.69% |
| Förändring sedan börsintroduktionen | 2,955.59% |
Senaste nyheter och uppdateringar
Recent updates
Uppdatering av berättelse • Jul 28
CME: Perpetual Futures Dispute And New Contracts Will Shape Earnings Profile
The analyst fair value estimate for CME Group has been trimmed by about $6.64 to $282.36, as analysts balance slightly higher projected revenue growth with lower profit margin assumptions and a modestly reduced future P/E multiple following a mix of recent target cuts and increases across the Street. Analyst Commentary Recent research on CME Group shows a split view, with some firms lifting price targets and ratings while others trim expectations and flag competitive threats.Seeking Alpha • Jul 23
CME Group's Strong Quarter Still Supports A Hold
Summary CME Group maintains strong core performance, posting record Q2 revenue and robust margins, yet the stock remains range-bound and fully valued. Q2 2026 highlights include $2.99 non-GAAP EPS, $1.71B revenue, 69.5% adjusted operating margin, and resilient trading volumes across key product lines. Capital return remains aggressive with $1.2B distributed via dividends and buybacks, backed by a strong balance sheet and disciplined expense management. I maintain a hold rating as CME's valuation prices in near-perfect execution, with limited upside absent major catalysts or volatility spikes. Read the full article on Seeking AlphaUppdatering av berättelse • Jul 09
CME: Crypto Perpetual Futures Dispute Will Reshape Long Term Earnings Power
The analyst price target for CME Group has been trimmed by about $14 to reflect slightly softer revenue growth assumptions, a modestly higher discount rate, and lower future P/E multiples that many analysts link to competitive concerns around perpetual futures, despite broadly constructive views on the core franchise. Analyst Commentary Recent research on CME Group highlights a split view, with some analysts seeing attractive upside after the share pullback and others focusing on competitive threats and pricing pressure.Uppdatering av berättelse • Jun 24
CME: Crypto Perpetual Futures Dispute Will Shape Future Earnings Power
The analyst price target for CME Group has shifted slightly lower, with fair value moving from about $306.47 to $302.60 as analysts weigh ongoing concerns around perpetual futures and potential multiple compression against views that recent share weakness and structural demand drivers still support an attractive long term setup. Analyst Commentary Recent research on CME Group shows a split between bullish analysts who see the recent pullback and product portfolio as supportive for long term value, and more cautious voices focused on competitive threats from perpetual futures and the potential impact on valuation multiples.Analysartikel • Jun 18
CME Group (CME) Stock Could Be 18% Undervalued After CEO Succession News
CME Group (CME) stock is in focus after the company confirmed a leadership transition that will see long time Chairman and CEO Terry Duffy move to Executive Chairman while President and CFO Lynne Fitzpatrick becomes CEO in 2027. See our latest analysis for CME Group. The leadership announcement landed against a weaker backdrop for CME Group stock, with the share price down 3.46% over the past day and 17.23% over the past 30 days, while the 5 year total shareholder return of 45.07% still...Uppdatering av berättelse • Jun 05
CME: Crypto And AI Futures Expansion Will Shape Future Earnings Power
Analysts have trimmed their average price target for CME Group to about $306.47. This reflects concerns that revenue momentum could soften as geopolitical volatility eases and that fresh competition in bitcoin perpetual futures may weigh on exchange valuations, even as several firms still see the competitive risk as manageable.Uppdatering av berättelse • May 15
CME: Mixed Street Views And New Markets Will Shape Future Earnings Power
Narrative Update on CME Group The analyst price target for CME Group has been trimmed by about $2, reflecting updated views on slightly softer revenue growth and a modestly lower future P/E multiple. At the same time, some analysts highlight areas of support such as commodities volumes as well as agriculture and prediction markets.Uppdatering av berättelse • Apr 27
CME: Volatile Street Views And New Futures Will Shape Trading Mix
Analysts have nudged their fair value estimate for CME Group down to $308.20 from $311.67, reflecting slightly softer revenue growth assumptions and a higher discount rate, partly balanced by a higher projected profit margin and a modestly lower future P/E, in line with the mix of recent price target trims and increases across the Street. Analyst Commentary Recent Street research on CME Group has been active on both sides, with several firms adjusting price targets and ratings in different directions.Uppdatering av berättelse • Apr 11
CME: Volatility And New Contracts Will Shape Rare Earths And Crypto Volumes
The updated analyst price target for CME Group has moved higher by about $5 to $311.67. This change reflects analysts' use of a slightly lower discount rate, a modestly higher assumed revenue growth rate, and a marginally higher future P/E multiple, even as they factor in a small trim to projected profit margins.Uppdatering av berättelse • Mar 26
CME: Volatility And New Contracts Will Shape Rare Earths And Volume Mix
Analysts have made a modest upward adjustment to the CME Group fair value estimate to about $307 from roughly $305, reflecting slightly revised assumptions for discount rate, revenue growth, profit margin, and future P/E following a mix of recent rating changes and price target tweaks across the Street. Analyst Commentary Recent research on CME Group reflects a mixed but generally balanced backdrop, with several firms adjusting ratings and price targets in different directions.Uppdatering av berättelse • Mar 11
CME: Volatility And New Contracts Will Shape Rare Earths And Clearing Outlook
Our analyst price target for CME Group has moved modestly higher to $305.21 from $299.29, as analysts factor in slightly stronger modeled revenue growth and profitability. This is partially offset by a more conservative future P/E assumption and mixed views on volume drivers across product lines.Uppdatering av berättelse • Feb 25
CME: Volatility And New Contracts Will Shape Futures And Clearing Outlook
The analyst price target for CME Group edges higher to $232, with recent updates reflecting analysts' focus on firmer commodities volumes, as well as a more expense conscious outlook in their refreshed earnings models. Analyst Commentary Recent Street research around CME Group reflects a mix of optimism on volumes and earnings power, alongside caution on valuation and the cost base.Uppdatering av berättelse • Feb 10
CME: Volatility And Prediction Markets Will Guide Futures And Clearing Expansion Outlook
The updated analyst price target for CME Group edges higher to about US$297 from roughly US$290, reflecting analysts' use of a slightly lower discount rate, a modestly higher assumed revenue growth rate, and a similar future P/E multiple despite a slightly lower profit margin input. Analyst Commentary Street research on CME Group in recent sessions centers on a cluster of revised price targets and at least one rating change, with several bullish analysts lifting their targets by varying dollar amounts and one major bank fine tuning its view in both directions over a short time frame.Uppdatering av berättelse • Jan 27
CME: Volatility And Prediction Markets Will Shape Futures Activity Outlook
The analyst price target for CME Group is now US$290.40, a move of about US$2 from the prior US$288.33, as analysts factor in slightly different assumptions for fair value, discount rate, revenue growth, profit margins, and future P/E following mixed recent research that includes both a modest target cut and an upgrade linked to a tilt toward volatility. Analyst Commentary Recent research on CME Group reflects a mix of optimism and caution, with one firm trimming its price target slightly and another upgrading the stock on what it sees as a better setup for volatility related trading activity.Uppdatering av berättelse • Jan 12
CME: Fee Moat And Prediction Markets Will Shape Futures Activity Outlook
Narrative Update: CME Group CME Group's fair value estimate has edged up by about $1 to roughly $288 per share, as analysts cite the company's strong futures and options moat, a higher price target range of up to $314, and interest in its role within prediction markets as key supports for the updated outlook. Analyst Commentary Recent Street research has been generally constructive on CME Group, with several bullish analysts adjusting their price targets higher and highlighting the company's futures and options franchise as a key support for valuation.Uppdatering av berättelse • Dec 27
CME: Fee Resilience And Prediction Markets Will Balance Lower Volatility Risks
Analysts have nudged their average price target on CME Group modestly higher, to approximately $287 from about $286, citing the company’s resilient fee-based revenue mix, strong competitive moat in futures and options, and supportive demand signals from prediction market partnerships despite some conflicting views on near term volume volatility. Analyst Commentary Recent Street research presents a mixed but generally constructive view on CME Group, with upward moves in price targets tempered by concerns around volume sensitivity and valuation risk if volatility normalizes.Uppdatering av berättelse • Dec 13
CME: Fee Resilience And New Prediction Markets Will Help Navigate Volatility
Analysts have raised their fair value estimate for CME Group by about $1 to roughly $286 per share, citing the company’s resilient clearing and transaction fee driven revenue base, modestly higher long term growth expectations, and a reinforced competitive moat highlighted in recent target revisions across the Street. Analyst Commentary Street research on CME Group reflects a wide range of views on valuation and execution, with recent target changes clustering around expectations for resilient fee income but diverging on the sustainability of growth and the impact of lower volatility.Uppdatering av berättelse • Nov 16
CME: Revenue Resilience And New Ventures Will Balance Volatility Risks Ahead
The average analyst price target for CME Group was raised by approximately $3 to $285, as analysts point to the firm's resilient revenue streams and strong market position amid continued macroeconomic uncertainty. Analyst Commentary Recent analyst activity reflects a mix of optimism and caution regarding CME Group's performance and outlook, particularly as the firm navigates shifting macroeconomic and market conditions.Aktieägarnas avkastning
| CME | US Capital Markets | US Marknad | |
|---|---|---|---|
| 7D | -1.0% | 1.0% | 1.0% |
| 1Y | -4.3% | 1.2% | 18.4% |
Avkastning vs industri: CME presterade sämre än US Capital Markets branschen som gav 1.2 % under det senaste året.
Avkastning vs Marknaden: CME presterade sämre än US marknaden som gav 18.4 % under det senaste året.
Prisvolatilitet
| CME volatility | |
|---|---|
| CME Average Weekly Movement | 4.7% |
| Capital Markets Industry Average Movement | 3.5% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stabil aktiekurs: CME har inte haft någon betydande prisvolatilitet under de senaste 3 månaderna jämfört med marknaden för US.
Volatilitet över tid: CME s veckovolatilitet ( 5% ) har varit stabil under det senaste året.
Om företaget
| Grundad | Anställda | VD OCH KONCERNCHEF | Webbplats |
|---|---|---|---|
| 1898 | 3,875 | Terry Duffy | www.cmegroup.com |
CME Group Inc. driver tillsammans med sina dotterbolag terminsmarknader för handel med terminer och optioner på terminskontrakt över hela världen. Företaget erbjuder termins- och optionsprodukter baserade på räntor, aktieindex och valutor, samt råvaror inom jordbruks-, energi- och metallsektorerna, liksom tjänster för handel med räntebärande värdepapper och valutor. Företaget tillhandahåller clearingtjänster, inklusive clearing, avveckling och garantier för termins- och optionskontrakt samt clearade swap-produkter som handlas via dess börser.
CME Group Inc. Sammanfattning av grunderna
| CME grundläggande statistik | |
|---|---|
| Börsvärde | US$93.25b |
| Vinst(TTM) | US$4.27b |
| Intäkter(TTM) | US$6.76b |
22.1x
P/E-förhållande14.0x
P/S-förhållandeÄr CME övervärderat?
Se Verkligt värde och värderingsanalysResultat & intäkter
| CME resultaträkning (TTM) | |
|---|---|
| Intäkter | US$6.76b |
| Kostnad för intäkter | US$0 |
| Bruttovinst | US$6.76b |
| Övriga kostnader | US$2.49b |
| Intäkter | US$4.27b |
Senast redovisade vinst
Jun 30, 2026
Nästa vinstdatum
n/a
| Vinst per aktie (EPS) | 11.86 |
| Bruttomarginal | 100.00% |
| Nettovinstmarginal | 63.12% |
| Skuld/egenkapitalförhållande | 12.9% |
Hur har CME utvecklats på lång sikt?
Se historisk utveckling och jämförelseUtdelningar
4.3%
Aktuell utdelningsavkastning43%
UtbetalningskvotGer CME en tillförlitlig utdelning?
Se CME utdelningshistorik och jämförelsetal| CME Group datum för utdelning | |
|---|---|
| Ex utdelningsdag | Sep 09 2026 |
| Utbetalningsdag för utdelning | Sep 25 2026 |
| Dagar till Ex-utdelning | 27 days |
| Dagar till utdelningsdag | 43 days |
Ger CME en tillförlitlig utdelning?
Se CME utdelningshistorik och jämförelsetalFöretagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/08/12 04:14 |
| Aktiekurs vid dagens slut | 2026/08/12 00:00 |
| Intäkter | 2026/06/30 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som används för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och handledningar på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
CME Group Inc. bevakas av 32 analytiker. 12 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Stephen Biggar | Argus Research Company |
| Benjamin Budish | Barclays |
| Roger Freeman | Barclays |